Astrana Health (NASDAQ:ASTH) PT Lowered to $45.00

Astrana Health (NASDAQ:ASTHGet Free Report) had its target price dropped by equities researchers at Stifel Nicolaus from $50.00 to $45.00 in a report released on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price target points to a potential upside of 27.33% from the company’s current price.

A number of other analysts have also commented on the company. Jefferies Financial Group initiated coverage on Astrana Health in a report on Monday, February 26th. They set a “buy” rating and a $50.00 price target on the stock. Truist Financial boosted their price target on shares of Astrana Health from $41.00 to $44.00 and gave the stock a “hold” rating in a report on Friday, March 1st.

Get Our Latest Stock Report on ASTH

Astrana Health Price Performance

Shares of ASTH stock traded down $2.59 on Wednesday, reaching $35.34. 7,238 shares of the company were exchanged, compared to its average volume of 152,303. The company has a current ratio of 2.11, a quick ratio of 2.11 and a debt-to-equity ratio of 0.42. The firm has a 50-day simple moving average of $40.36. The stock has a market capitalization of $1.98 billion, a P/E ratio of 26.77, a price-to-earnings-growth ratio of 1.20 and a beta of 1.12. Astrana Health has a one year low of $28.86 and a one year high of $45.71.

Astrana Health (NASDAQ:ASTHGet Free Report) last posted its earnings results on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The business had revenue of $404.36 million for the quarter, compared to the consensus estimate of $413.84 million. During the same period in the previous year, the firm earned $0.42 earnings per share. The company’s revenue was up 19.9% on a year-over-year basis. As a group, sell-side analysts predict that Astrana Health will post 1.65 EPS for the current year.

About Astrana Health

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Articles

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.